YTENQ (Yield10 Bioscience) Retained Earnings: $-419.86 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YTENQ Yield10 Bioscience Inc YTENQ
16 GF Score
Price $0.00
View Full Analysis

What is Yield10 Bioscience Retained Earnings?

Yield10 Bioscience YTENQ 16 Retained Earnings is $-419.86 Mil as of Jun. 2024. GuruFocus rates YTENQ with a GF Score™ of 16/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Yield10 Bioscience's retained earnings for the quarter that ended in Jun. 2024 was $-419.86 Mil.

Yield10 Bioscience's quarterly retained earnings declined from Dec. 2023 ($-414.15 Mil) to Mar. 2024 ($-416.62 Mil) and declined from Mar. 2024 ($-416.62 Mil) to Jun. 2024 ($-419.86 Mil).

Yield10 Bioscience's annual retained earnings declined from Dec. 2021 ($-386.13 Mil) to Dec. 2022 ($-399.70 Mil) and declined from Dec. 2022 ($-399.70 Mil) to Dec. 2023 ($-414.15 Mil).


Yield10 Bioscience  (OTCPK:YTENQ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Yield10 Bioscience Retained Earnings Historical Data

* Premium members only.

The historical data trend for Yield10 Bioscience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yield10 Bioscience Retained Earnings Chart

Yield10 Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -364.89 -375.10 -386.13 -399.70 -414.15

Yield10 Bioscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -407.16 -410.89 -414.15 -416.62 -419.86
YTENQ
16GF Score
Yield10 Bioscience Inc YTENQ
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yield10 Bioscience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-419.86 Mil mean?
Yield10 Bioscience (YTENQ) has a Retained Earnings of $-419.86 Mil as of Jun. 2024. Retained earnings is the amount of net income not issued to shareholders. View historical data on Yield10 Bioscience and its competitors.
Is Yield10 Bioscience's Retained Earnings too high?
Yield10 Bioscience's current Retained Earnings is $-419.86 Mil. Overall, Yield10 Bioscience has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Yield10 Bioscience's Retained Earnings compare to GNVR and CTVA?
Yield10 Bioscience's Retained Earnings of $-419.86 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for an Agriculture company?
A good Retained Earnings depends on the Agriculture industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Yield10 Bioscience and its competitors. Yield10 Bioscience's current Retained Earnings is $-419.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yield10 Bioscience stock overvalued right now?
Yield10 Bioscience (YTENQ) has a current Retained Earnings of $-419.86 Mil. The current Retained Earnings is $-419.86 Mil. Yield10 Bioscience's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Yield10 Bioscience (YTENQ), the current Retained Earnings is $-419.86 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yield10 Bioscience Business Description

Address 19 Presidential Way, Woburn, MA, USA, 01801
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.
16GF Score

Get the complete analysis for YTENQ

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price